Literature DB >> 2426712

Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides.

B D Davis, L L Chen, P C Tai.   

Abstract

Among the pleiotropic effects of aminoglycosides, their irreversible uptake and their blockade of initiating ribosomes have appeared to explain their bactericidal action, while the contributions of translational misreading and membrane damage and the mechanism of that damage have remained uncertain. We now present evidence that incorporation of misread proteins into the membrane can account for the membrane damage. The bactericidal action thus appears to result from the following sequence, in which each step is essential: slight initial entry of the antibiotic; interaction with chain-elongating ribosomes, resulting in misreading; incorporation of misread protein into the membrane, creating abnormal channels; increased (and irreversible) entry through these channels, and hence increased misreading and formation of channels; and, finally, blockade of initiating ribosomes. This mechanism can account for several previously unexplained observations: that streptomycin uptake requires protein synthesis during, but not after, the lag before the membrane damage; that streptomycin-resistant cells, which fail to take up streptomycin, can do so after treatment by another aminoglycoside; and that puromycin at moderate concentrations accelerates streptomycin uptake, while high concentrations (which release shorter chains) prevent it. In addition, puromycin, prematurely releasing polypeptides of normal sequence, also evidently creates channels, since it is reported to promote streptomycin uptake even in streptomycin-resistant cells. These findings imply that normal membrane proteins must be selected not only for a hydrophobic anchoring surface, but also for a tight fit in the membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426712      PMCID: PMC386460          DOI: 10.1073/pnas.83.16.6164

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  THE SEQUENCE OF SOME EFFECTS OF STREPTOMYCIN IN ESCHERICHIA COLI.

Authors:  D T DUBIN; R HANCOCK; B D DAVIS
Journal:  Biochim Biophys Acta       Date:  1963-08-13

2.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

3.  Properties of initiation-free polysomes of Escherichia coli.

Authors:  P C Tai; B J Wallace; E L Herzog; B D Davis
Journal:  Biochemistry       Date:  1973-02       Impact factor: 3.162

4.  Cyclic blockade of initiation sites by streptomycin-damaged ribosomes in Escherichia coli: an explanation for dominance of sensitivity.

Authors:  B J Wallace; B D Davis
Journal:  J Mol Biol       Date:  1973-04-05       Impact factor: 5.469

5.  A ribosomal ambiguity mutation.

Authors:  R Rosset; L Gorini
Journal:  J Mol Biol       Date:  1969-01-14       Impact factor: 5.469

6.  The mechanism of protein secretion across membranes.

Authors:  B D Davis; P C Tai
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

7.  Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium.

Authors:  M E Muir; R S van Heeswyck; B J Wallace
Journal:  J Gen Microbiol       Date:  1984-08

8.  Induction of streptomycin uptake in resistant strains of Escherichia coli.

Authors:  J V Höltje
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

9.  Role of ribosome recycling in uptake of dihydrostreptomycin by sensitive and resistant Escherichia coli.

Authors:  C Hurwitz; C B Braun; C L Rosano
Journal:  Biochim Biophys Acta       Date:  1981-01-29

10.  Streptomycin causes misreading of natural messenger by interacting with ribosomes after initiation.

Authors:  P C Tai; B J Wallace; B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

View more
  83 in total

1.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

Review 2.  Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.

Authors:  Marilyn N Martinez; Mark G Papich; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

3.  Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interaction.

Authors:  Sven N Hobbie; Peter Pfister; Christian Brüll; Eric Westhof; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Effects of production of abnormal proteins on the rate of killing of Escherichia coli by streptomycin.

Authors:  M A Wyka; A C St John
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 5.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

6.  Genetic and structural analysis of base substitutions in the central pseudoknot of Thermus thermophilus 16S ribosomal RNA.

Authors:  Steven T Gregory; Albert E Dahlberg
Journal:  RNA       Date:  2009-02       Impact factor: 4.942

7.  Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  Calvin Ho-Fung Lau; Sebastien Fraud; Marcus Jones; Scott N Peterson; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

8.  Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Thomas Krahn; Christie Gilmour; Justin Tilak; Sebastien Fraud; Nicholas Kerr; Calvin Ho-Fung Lau; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.

Authors:  Tobias Dörr; Marin Vulić; Kim Lewis
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

10.  Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa.

Authors:  Julie M Struble; Ryan T Gill
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.